1. Stocks
  2. Eiko Lifesciences Ltd.
  3. Swot
swot-logo

Eiko Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Eiko Lifesciences Ltd. has 13 Strengths, 8 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Promoter holding increased more than 2% QoQ

Companies with no Debt

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Growth stocks, promoters increasing shareholding

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Declining Revenue every quarter for the past 2 quarters

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Declining profitability: Falling ROCE

Stocks Underperforming their Industry Price Change in the Quarter

Companies with improving valuation scores after share price falls

Promoters increasing shareholding QoQ

Significant Change in Promoter Shareholding - Latest Quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)